ForCast Orthopedics Receives Orphan Drug Designation From FDA for the Treatment of Periprosthetic Joint Infection finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
ForCast Orthopedics Receives Orphan Drug Designation From FDA for the pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
ForCast Orthopedics has announced FDA qualified infectious disease product designation for its FC001 periprosthetic joint infection treatment program, according to a press release.The FC001 program is being developed to facilitate a targeted antibiotic therapy in patients with periprosthetic joint infection, according to the release.